Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MABF925 Anti-FcγRII (human) Antibody, clone AT10

MABF925
100 μg  
Purchase on Sigma-Aldrich

Különleges ajánlatok

Áttekintés

Replacement Information

Különleges ajánlatok

Kulcsspecifikációk táblázata

Species ReactivityKey ApplicationsHostFormatAntibody Type
HFCMPurifiedMonoclonal Antibody
Description
Catalogue NumberMABF925
DescriptionAnti-FcγRII (human) Antibody, clone AT10
Alternate Names
  • CD32CDw32
  • Fc-gamma RII-a
  • Fc-gamma RII-b
  • Fc-gamma RII-c
  • Fc-gamma-RIIa
  • Fc-gamma-RIIb
  • Fc-gamma-RIIc
  • FcRII-a
  • FcRII-b
  • FcRII-c
  • IgG Fc receptor II-a
  • IgG Fc receptor II-b
  • IgG Fc receptor II-c
  • Low affinity immunoglobulin gamma Fc region receptor II-a
  • Low affinity immunoglobulin gamma Fc region receptor II-b
  • Low affinity immunoglobulin gamma Fc region receptor II-c
Background InformationFcγRI/CD64, FcγRII/CD32, FcγRIII/CD16, and FcγRIV/CD16-2 represent the four known classes of IgG Fc receptors (FcγRs). FcγRII, FcγRIII, and FcγRIV are low-affinity receptors for monomeric IgG, whereas FcγRI is the only high-affinity FcγR. FcγRs play important roles in inflammatory cell activation, clearance, presentation of Ag, and maintenance of IgG homeostasis. In addition to binding immune complex (IC), FcγRs have been shown to bind non-IgG ligands. For example, FcγRII is shown to bind oxLDL, while FcγRIII binding to an E. coli component is reported to negatively regulate the function of macrophage receptor with collagenous structure (MARCO). FcyRII activation is also reported to transduce a negative regulatory signal against CD38 crosslinking-induced proliferation of resting mature B cells. Low affinity immunoglobulin gamma Fc region receptor II-a/b/c (IgG Fc receptor II-a/-b/-c, CDw32, Fc-gamma RII-a/-b/-c, Fc-gamma-RIIa/b/c, FcRII-a/-b/-c, CD32) are encoded by the FCGR2A/B/C (CD32, FCG2, IGFR2) genes in human (UniProt P12318, P31994, P31995; Gene ID 2212, 2213, 9103). The FcγRIIs encoded by the three genes are highly conserved in their extracellular portion, with significant variation in the transmembrane and intracellular regions. All three types of transcripts alternative splicing to generate additional isoforms.
References
Product Information
FormatPurified
PresentationPurified mouse monoclonal IgG1κ antibody in PBS without preservatives.
Quality LevelMQ100
Applications
ApplicationAnti-FcγRII (human) Antibody, clone AT10 is an antibody against FcγRII for use in Flow Cytometry.
Key Applications
  • Flow Cytometry
Application NotesFlow Cytometry Analysis: 25 µg/mL from a representative lot was conjugated with FITC and detected FcγRII surface expression among the monocytes, but not the lymphocytes population of human peripheral blood mononuclear cells (PBMCs) by flow cytometry (Courtesy of Professor Martin J. Glennie, University of Southampton, UK).
Flow Cytometry Analysis: A representative lot was conjugated with Phycoerythrin (PE) and immunostained the surface of human Burkitt's lymphoma Ramos cells transfected with FcγRIIB, but not untransfected Ramos cells (Courtesy of Professor Martin J. Glennie, University of Southampton, UK).
Flow Cytometry Analysis: Clone AT10 hybridoma culture supernatant was employed to detect FcγRII-positive peripheral blood lymphocytes (PBLs) by flow cytometry (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Immunoprecipitation Analysis: A representative lot immunoprecipitated FcγRII from human K562 erythroleukemic cells (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Affinity Binding Assay: Affinity binding study using the Fab' fragment of clone AT10 showed an equilibrium binding constant (Ka) of 5.3 x 10^8/M and a total of 1.5 x 10^5 binding sites per K562 cell (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Neutralization Analysis: The F(ab')2 fragment of clone AT10 blocked FcγRII-dependent B-cell activation by a chimeric anti-CD40 mAb with human IgG1 Fc (ChiLob 7/4 h1) induced in the presence of FcγRII-overexpressing 293F as the crosslinking cells (White, A.L., et al. (2015). Cancer Cell 27(1):138–148).
Neutralization Analysis: Both the Fab' and F(ab')2 fragments of clone AT10, but not control IgG1 or control F(ab')2, blocked K562 cells from rosetting with rabbit IgG-coated chick red blood cells (CRBCs) (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Neutralization Analysis: The F(ab')2 fragment of clone AT10 blocked the lysis of chick red blood cells (CRBCs) by effector cells via redirected cellular cytotoxicity (RCC; antibody-dependent cell-mediated cytolysis; ADCC) mediated by an anti-CRBC monoclonal antibody (E11C12) (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Biological Information
ImmunogenHuman erythroleukaemic K562 cells.
EpitopeExtracellular domain.
CloneAT10
ConcentrationPlease refer to lot specific datasheet.
HostMouse
SpecificityClone AT10 targets the extracellular domain of human FcγRII and blocks its Fc binding activity. Expected to bind all three human FCGR2 genes-encoded FcγRII spliced isoforms reported by UniProt (P12318, P31994 & P31995).
IsotypeIgG1κ
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Gene Symbol
  • FCGR2A
  • FCGR2B
  • FCGR2C
  • CD32
  • FCG2
  • IGFR2
Purification MethodProtein G Purified
UniProt Number
Molecular Weight31.30 kDa (FcγRIIA), 29.49 kDa (FcγRIIB1), 27.39 kDa (FcγRIIB2), 29.22 kDa (FcγRIIB3), 31.03 kDa (FcγRIIC1), 25.69 kDa (FcγRIIC2), 24.82 kDa (FcγRIIC3), 21.35 kDa (FcγRIIC4) calculated. ~42 kDa (glycosylated) and ~36 kDa (PNGase F treated) reported (Greenman, J., et al. (1991). Mol. Immunol. 28(11):1243-1254).
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Flow Cytometry analysis of human PBMCs.

Flow Cytometry Analysis: 1.0 µg of this antibody detected FcγRII in 1x10E6 human peripheral blood mononuclear cells (PBMCs).
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Packaging Information
Material Size100 μg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalógusszám GTIN
MABF925 04055977329605

Documentation

Anti-FcγRII (human) Antibody, clone AT10 MSDS

Title

Safety Data Sheet (SDS) 

Anti-FcγRII (human) Antibody, clone AT10 Certificates of Analysis

TitleLot Number
Anti-FcγRII (human), clone AT10 - 3314245 3314245
Anti-FcγRII (human), clone AT10 - 3419583 3419583
Anti-FcγRII (human), clone AT10 - 3584358 3584358
Anti-FcγRII (human), clone AT10 - 3994024 3994024
Anti-FcγRII (human), clone AT10 - 4211818 4211818
Anti-FcγRII (human), clone AT10 -Q2651593 Q2651593
Anti-FcγRII (human), clone AT10 Monoclonal Antibody 3156850
Anti-FcγRII (human), clone AT10 Monoclonal Antibody 2993682